Walgreens Boots Alliance Inc (NASDAQ:WBA) Position Boosted by Toronto Dominion Bank
Toronto Dominion Bank grew its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 30.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 923,186 shares of the pharmacy operator’s stock after purchasing an additional 213,130 shares during the period. Toronto Dominion Bank owned about 0.10% of Walgreens Boots Alliance worth $50,458,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Family Legacy Inc. lifted its stake in shares of Walgreens Boots Alliance by 2.5% in the 1st quarter. Family Legacy Inc. now owns 8,020 shares of the pharmacy operator’s stock valued at $442,000 after purchasing an additional 195 shares during the last quarter. Cable Hill Partners LLC raised its holdings in Walgreens Boots Alliance by 40.0% during the first quarter. Cable Hill Partners LLC now owns 700 shares of the pharmacy operator’s stock valued at $44,000 after buying an additional 200 shares in the last quarter. Exencial Wealth Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 1.0% in the first quarter. Exencial Wealth Advisors LLC now owns 20,134 shares of the pharmacy operator’s stock worth $1,274,000 after buying an additional 207 shares during the last quarter. Hammer Asset Management LLC lifted its position in shares of Walgreens Boots Alliance by 0.6% in the first quarter. Hammer Asset Management LLC now owns 38,043 shares of the pharmacy operator’s stock worth $2,407,000 after buying an additional 214 shares during the last quarter. Finally, Alpha Quant Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 0.9% during the 1st quarter. Alpha Quant Advisors LLC now owns 23,730 shares of the pharmacy operator’s stock worth $1,501,000 after acquiring an additional 216 shares in the last quarter. Institutional investors own 59.80% of the company’s stock.
In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $50.48, for a total value of $10,869,505.04. Following the completion of the sale, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at approximately $18,064,318.48. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 15.73% of the stock is owned by corporate insiders.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The company had revenue of $34.59 billion during the quarter, compared to analyst estimates of $34.52 billion. During the same period in the previous year, the company earned $1.53 earnings per share. The company’s quarterly revenue was up .7% compared to the same quarter last year. Sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.98 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Tuesday, August 20th will be given a dividend of $0.458 per share. The ex-dividend date is Monday, August 19th. This represents a $1.83 dividend on an annualized basis and a yield of 3.19%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. Walgreens Boots Alliance’s payout ratio is 30.40%.
A number of brokerages have recently commented on WBA. Bank of America lowered their price objective on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a report on Monday, June 3rd. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 target price for the company. in a report on Monday, June 10th. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, June 28th. Morgan Stanley decreased their target price on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating for the company in a research report on Friday, August 23rd. Finally, JPMorgan Chase & Co. lowered their price target on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a report on Friday, June 28th. Six investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $63.65.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: What is a front-end load?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.